IP Library › Granted Patent US 8,058,301
Granted Patent B2
US 8,058,301 · App. 11/013,111 · Granted Nov 15, 2011

Salt hydrates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,058,301
App. No.
11/013,111
Granted
Nov 15, 2011
Kind
B2
Abstract

The invention relates to new forms of salts of valsartan or crystalline, also partly crystalline and amorphous salts of valsartan, the respective production and usage, and pharmaceutical preparations containing such a salt.

Claims (10)

1. An amorphous calcium salt of valsartan characterized by

(i) a water content of 11 ±2%

(ii) a glass transition of 94 ±20° C.

(iii) no melting point; and

(iv) no enthalpy of fusion.

2. An amorphous calcium salt of valsartan characterized by

(i) a water content of 9 ±2%

(ii) a glass transition of 143 ±20° C.

(iii) no melting point; and

(iv) no enthalpy of fusion.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2011
From: NOVARTIS AG
To: NOVARTIS PHARMACEUTICALS CORPORATION
Reel/Frame 026002/0790 →